The USFDA recently issued a warning letter to young adults who are using the antidepressant Paxil, stating that this drug may increase the risk of suicidal behavior in young adults. The warning letter came with the changes in labeling of both Paxil and Paxil CR, the controlled release form of the drug which is also called paroxetine.
Read the CNN Health full report.The FDA reported that there were 11 suicide attempts -- none resulting in death -- among the patients who received Paxil in the trials. Just one of the dummy pill patients attempted suicide. Given that small number, the results "should be interpreted with caution," the FDA said.
Eight of the 11 attempts were made by patients between the ages of 18 and 30. All trial patients suffered from psychiatric disorders, including major depression.
» DOJ Investigation of Paxil Widens from PharmaGazette
The U.S. Department of Justice confirmed that its investigation into whether GlaxoSmithKline withheld data concerning adverse risk associated with Paxil has been expanded to include the U.S. attorney's office in Boston and is being coordinated in W... [Read More]
Tracked on: June 25, 2008 12:32 PM | Permalink to Trackback